# Which GLP-1 Pills Are in Development? Aleniglipron and Elecoglipron | Buy This GLP

Aleniglipron and elecoglipron have reached phase 3. Learn what their earlier trials measured and how they differ from approved GLP-1 pills.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/which-glp1-pills-are-in-development
Updated: 2026-11-15
Published: 2026-09-17

[← Research](https://buythisglp.com/research)

Evidence

# Which GLP-1 Pills Are in Development? Aleniglipron and Elecoglipron

See which oral GLP-1 drugs are still in trials, which program stopped, and which tablets are already FDA-approved.

Editorial profile: [Carla Medina](https://buythisglp.com/authors/carla-medina)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20264 min readUpdated November 2026

Aleniglipron, week 36, placebo-adjusted · 45 mg · −8.2% · 90 mg · −9.8% · 120 mg · −11.3% · ACCESS phase 2b · 230 adults randomized.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

## Key takeaways

-   Aleniglipron and elecoglipron are in phase 3 development.
-   The sponsor stopped developing TERN-601 after a liver safety signal.
-   Wegovy and Foundayo tablets are FDA-approved options for eligible adults.

Aleniglipron and elecoglipron are investigational oral GLP-1 drugs that have reached phase 3 [\[2\]](https://buythisglp.com/research/which-glp1-pills-are-in-development#ref-2) [\[5\]](https://buythisglp.com/research/which-glp1-pills-are-in-development#ref-5). If you are comparing [GLP-1 pill and injection prices](https://buythisglp.com/research/is-the-glp1-pill-cheaper-than-the-injection), distinguish approved products from drugs still in trials. A trial result cannot establish an approval date or retail price.

## Aleniglipron

The ACCESS phase 2b trial randomized 230 adults with overweight or obesity [\[1\]](https://buythisglp.com/research/which-glp1-pills-are-in-development#ref-1). At 36 weeks, the 45 mg, 90 mg and 120 mg groups lost an estimated 8.2, 9.8 and 11.3 percentage points more than placebo, respectively. In its November SEC filing, Structure Therapeutics said its phase 3 ACCOMPLISH program was underway [\[2\]](https://buythisglp.com/research/which-glp1-pills-are-in-development#ref-2).

## Elecoglipron

Researchers studied blood glucose and weight in separate phase 2 programs. Our [elecoglipron guide](https://buythisglp.com/research/what-is-elecoglipron) gives more context on its early results. SOLSTICE primarily measured hemoglobin A1C in adults with type 2 diabetes [\[3\]](https://buythisglp.com/research/which-glp1-pills-are-in-development#ref-3). VISTA assessed weight outcomes in adults with overweight or obesity [\[4\]](https://buythisglp.com/research/which-glp1-pills-are-in-development#ref-4). AstraZeneca is testing the drug for weight management in registered phase 3 studies [\[5\]](https://buythisglp.com/research/which-glp1-pills-are-in-development#ref-5).

## TERN-601

Terns Pharmaceuticals stopped developing TERN-601 after liver enzyme elevations in three phase 2 participants [\[6\]](https://buythisglp.com/research/which-glp1-pills-are-in-development#ref-6). One event was reported as serious drug-induced liver injury. The findings concern this candidate and do not establish the liver risk of other GLP-1 pills.

## Which pills are already approved in the US?

Wegovy tablets contain semaglutide, and Foundayo tablets contain orforglipron [\[7\]](https://buythisglp.com/research/which-glp1-pills-are-in-development#ref-7) [\[8\]](https://buythisglp.com/research/which-glp1-pills-are-in-development#ref-8). The FDA has approved both for weight management in eligible adults. Each has its own label and instructions.

## Frequently asked

Which GLP-1 pills are in phase 3 development?

Aleniglipron and elecoglipron are in phase 3 development as of November 2026.

Why did TERN-601 development stop?

The sponsor ended development primarily because of liver safety findings in phase 2.

Which GLP-1 pills are already FDA-approved for weight management?

Wegovy tablets contain semaglutide. Foundayo tablets contain orforglipron. Both are approved for weight management in eligible adults.

## Sources

1.  \[1\] Rosenstock J, Lingvay I, Ryan D, et al. (2026). Oral small molecule GLP-1 receptor agonist aleniglipron in people with overweight or obesity Nature Medicine. [PMID 42249138](https://pmc.ncbi.nlm.nih.gov/articles/PMC13472849/)
2.  \[2\] Structure Therapeutics Inc. (2026). Form 10-Q for quarter ended September 30, 2026 U.S. Securities and Exchange Commission. [Source](https://www.sec.gov/Archives/edgar/data/1888886/000110465926124503/gpcr-20260930x10q.htm)
3.  \[3\] Aroda VR, Davies MJ, Maaske J, et al. (2026). Elecoglipron in adults with type 2 diabetes (SOLSTICE) The Lancet. [PMID 42259343](https://pubmed.ncbi.nlm.nih.gov/42259343/)
4.  \[4\] Davies MJ, Aroda VR, Rosenstock J, et al. (2026). Elecoglipron in adults with obesity or overweight (VISTA) The Lancet. [PMID 42259337](https://pubmed.ncbi.nlm.nih.gov/42259337/)
5.  \[5\] AstraZeneca (2026). Phase 3 master protocol for elecoglipron in weight management (NCT07667803) ClinicalTrials.gov. [Source](https://clinicaltrials.gov/study/NCT07667803)
6.  \[6\] Garvey WT, et al. (2026). Oral GLP-1RA TERN-601 for Adults With Obesity/Overweight Obesity. [PMID 42528333](https://onlinelibrary.wiley.com/doi/full/10.1002/oby.70271)
7.  \[7\] Novo Nordisk Inc. (2026). Wegovy prescribing information DailyMed, U.S. National Library of Medicine. [Source](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
8.  \[8\] Eli Lilly and Company (2026). Foundayo prescribing information U.S. Food and Drug Administration. [Source](https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/220934Orig1s000lbl.pdf)

## Where to get it

### Price the oral sellers

Switch the desk to tablets and it prices the oral product itself, never a figure borrowed from the same seller's injection page.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
